Label-maker Avery Dennison Corporation, whose compliance problems in China were described in an LA Times story last January, has resolved civil and administrative charges brought by the Securities and Exchange Commission. The SEC filed settled enforcement actions in the United States District Court for the Central District of California charging Avery with violating the FCPA’s […]
Search Results for: label/Lockheed – Page 3
This post continues from Part One: Vicarious Liability and Part Two: A Flock of Foreign Officials.
This post continues from Part One: Vicarious Liability. There are several types of foreign officials that interact with a franchise’s broad array of potential agents abroad, which generates anti-corruption risks.
John Russell, the managing editor of London-based Ethical Corporation magazine, has a nice article here about enforcement of the Foreign Corrupt Practices Act against European companies. This “new” FCPA compliance risk, the article says, is catching a lot of people by surprise. But it’s today’s reality, so get used to it. Here’s a sample from […]
Since the start of the Ukraine crisis, NATO Secretary General Anders Fogh Rasmussen has called on NATO countries to increase defense spending. Poland has announced plans to accelerate a major military modernization program. And Latvia, Lithuania, Romania and the Czech Republic have all promised to increase their defense spending.
Where do we go when we need help with the Foreign Corrupt Practices Act? Our top choices are likely to include one or more of the following: 1. FCPA Digest of Cases and Review Releases Relating to Bribes to Foreign Officials under the Foreign Corrupt Practices Act of 1977 (the “FCPA Digest”). Written by Danforth […]
Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said Wednesday.
Tantalum, courtesy of Enough Project via YouTubeThe federal appeals court for the D.C. circuit issued its opinion Monday in National Association of Manufacturers (NAM), et al., v. Securities and Exchange Commission that partially struck down the SEC’s conflict minerals disclosure rule.